2m 2m 2m 2m 2m 2m 2m
United Therapeut (UTHR)
NASDAQ
$539.70-$2.00 (-0.37%)
Price as of Oct 02, 2026 7:57 PM EDT- $24.5BMarket Cap
- 19.56%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
United Therapeut (UTHR)
$539.70-$2.00 (-0.37%)
UTHR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $541.70 | ||
Change | -$29.68 (-5.19%) | ||
Open | $570.00 | ||
High | $577.02 | ||
Low | $541.27 | ||
Previous Close | $571.38 | ||
Volume | 1,239,827 | ||
30-Day Average Volume | 946,586 | ||
1-Week Change | 13.93% | ||
1-Month Change | 10.10% | ||
1-Year Change | 19.56% | ||
3-Year Change | 143.86% | ||
5-Year Change | 191.39% | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $7.2B | ||
Market Cap | $24.5B | ||
Enterprise Value | $22.9B | ||
Period: QTR TTM FY | |||
Revenue | $783.3M | ||
Net Income | $333.0M | ||
Free Cash Flow | $205.6M | ||
EBIT | $372.7M | ||
EBITDA | $396.9M | ||
Net Working Capital | $2.9B | ||
EPS | $7.27 | ||
Enterprise Value/EBITDA | 58 | ||
Enterprise Value/Revenue | 29 | ||
P/B | 4 | ||
P/E | 79 | ||
PEG | 3 | ||
Price/Free Cash Flow | 119 | ||
Price/Operating Cash Flow | 78 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 2 : 1 | ||
Last Split Date | 09/23/2009 | ||
Earnings & Revenue